Cigarette smoking contributes to idiopathic pulmonary fibrosis associated with emphysema

Chinese Medical Journal

Volumn 127, Issue 3, 2014, Pages 469-474

  Ye, Qiao ^a   Huang, Ke Wu ^a   Ding, Yi ^a   Lou, Bao Hui ^a   Hou, Zi Liang ^a   Dai, Hua Ping ^a   Wang, Chen ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Emphysema; Idiopathic pulmonary fibrosis; Smoking

Indexed keywords

CARBON MONOXIDE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DYSPNEA; EMPHYSEMA; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PULMONARY HYPERTENSION; RESIDUAL VOLUME; RISK ASSESSMENT; SMOKING; SURVIVAL RATE; AGED; COMPLICATION; IDIOPATHIC PULMONARY FIBROSIS; LUNG EMPHYSEMA; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; SMOKING;

EID: 84893097584     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131684     Document Type: Article

References (26)

1. Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 1993; 60: 354-358.
2. Cottin V. The impact of emphysema in pulmonary fibrosis. Eur Respir Rev 2013; 22: 153-157.
3. Cottin V, Nunes H, Mouthon L, Gamondes D, Lazor R, Hachulla E, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63: 295-304.
4. Schmidt SL, Nambiar AM, Tayob N, Sundaram B, Han MK, Gross BH, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011; 38: 176-183.
5. Mejia M, Carrillo G, Rojas Serrano J, Estrada A, Suarez T, Alonso D, et al. Idiopathic pulmonary fibrosis and emphysema. Decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
6. Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 2012; 141: 222-231.
7. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
8. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin section CT obtained at 10 mm increments versus limited three level thin section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol 1997; 169: 977-983.
9. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144: 234-240.
10. Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011; 16: 326-331.
11. Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008; 177: 190-194.
12. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, et al. COPD Gene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364: 897-906.
13. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, Slifer SH, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172: 1146-1152.
14. Taskar CF, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006; 3: 293-298.
15. Camp PG, Coxson HO, Levy RD, Pillai SG, Anderson W, Vestbo J, et al. Sex differences in emphysema and airway disease in smokers. Chest 2009; 136: 1480-1488.
16. Mura M, Zompatori M, Pacilli AM, Fasano L, Schiavina M, Fabbri M. The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care 2006; 51: 257-265.
17. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie Leblond I, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-593.
18. Hoyle GW, Li J, Finkelstein JB, Eisenberg T, Liu JY, Lasky JA, et al. Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet derived growth factor. Am J Pathol 1999; 154: 1763-1775.
19. Lundblad LK, Thompson Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, et al. Tumor necrosis factor alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005; 171: 1363-1370.
20. Zhao Y, Cui A, Wang F, Wang X, Chen X, Jin M, et al. Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema. Chin Med J 2012; 125: 3015-3021.
21. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105: 13051-13056.
22. Albaugh G, Kann B, Strande L, Vemulapalli P, Hewitt C, Alexander JB. Nicotine induces endothelial TNF alpha expression, which mediates growth retardation in vitro. J Surg Res 2001; 99: 381-384.
23. Zoppini G, Faccini G, Muggeo M, Zenari L, Falezza G, Targher G. Elevated plasma levels of soluble receptors of TNF alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes. J Clin Endocrinol Metab 2001; 86: 3805-3808.
24. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994; 150: 696-703.
25. Aduen JF, Zisman DA, Mobin SI, Venegas C, Alvarez F, Biewend M, et al. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease. Mayo Clin Proc 2007; 82: 48-54.
26. Kiakouama L, Cottin V, Glerant JC, Bayle JY, Mornex JF, Cordier JF. Conditions associated with severe carbon monoxide diffusion coefficient reduction. Respir Med 2011; 105: 1248-1256.